Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Phase IV Open Label Comparative Study Of Tranexamic Acid Plus Standard Of Care Vs Standard Of Care For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

NCT00827931 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00827931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Phase IV Open Label Comparative Study Of Tranexamic Acid Plus Standard Of Care Vs Standard Of Care For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2009
Completion date
May 31, 2011
Enrollment
94 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract surgical procedures, colectomy, esophagectomy, gastrectomy, pancreaticoduodenectomy